Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Promethazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 3/20 | 0.81 |
| ▸ | LMNA | P02545 | 4/20 | 0.83 |
| ▸ | MAPT | P10636 | 3/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.83 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.83 |
| ▸ | GFER | P55789 | 3/20 | 0.83 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.83 |
| ▸ | GMNN | O75496 | 1/20 | 0.83 |
| ▸ | BLM | P54132 | 1/20 | 0.83 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.81 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.81 |
| ▸ | HTR1A | P08908 | 5/20 | 0.81 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.81 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.81 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.81 |
| ▸ | DRD3 | P35462 | 5/20 | 0.81 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Promethazine SCHEMBL11655557 | 0.99 | CYP2D6 (0.83) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL5501515 | 0.91 | LMNA (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL27559626 | 0.91 | LMNA (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL29390401 | 0.91 | LMNA (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL5425141 | 0.91 | LMNA (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL2962420 | 0.91 | LMNA (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL41904 | 0.91 | LMNA (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL3991025 | 0.90 | LMNA (0.97) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| (S)-Promethazine SCHEMBL2900853 | 0.90 | CYP2D6 (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 | |
| Promethazine SCHEMBL26777 | 0.90 | CYP2D6 (1.00) | LMNAMAPTSMN1; SMN2KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6290949-B1 | USED TO TREAT RESTENOSIS, ESPECIALLY WHEN INCIDENT TO INJURY BY ANGIOPLASTY. | FRENCH BRENT A (US) | 2001-09-18 | — | — | US | disclosed |